Document is current
Any future updates will be listed below
-
Authors
Riccetti, Nicola http://orcid.org/0000-0002-3178-7892
Hempler, Isabelle
Hermes-Moll, Kerstin http://orcid.org/0000-0003-0176-5569
Heidt, Vitali
Bayer, Oliver http://orcid.org/0000-0003-4648-9481
Walawgo, Thomas
Merbach, Martin
Singer, Susanne http://orcid.org/0000-0001-5784-7964
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113529)
- License Information
-
More Information
Article History
Received: 20 November 2021
Accepted: 2 May 2022
First Online: 22 June 2022
Declarations
:
: The study was carried out in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Ethical approval was obtained from the Rhineland-Palatinate State Medical Association (2019–14424). Data collection was anonymous and participation was on a voluntary base.
: Participants were informed that data were collected to be published in scientific journal.
: Susanne Singer received honoraria from Lilly and Pfizer, all outside of the submitted work. The other authors declare that they have no conflict of interest.
